TL

Tammy Lavery — 510(k) & De Novo Consultant (Cardiovascular/Radiology)

VP, Regulatory Affairs and Quality Assurance

A seasoned Global Quality and Regulatory Compliance Executive with over two decades of leadership in the medical device industry. Tammy Lavery possesses deep expertise in securing FDA approvals, developing and implementing global regulatory strategies, and managing robust Quality Management Systems (ISO 13485, MDSAP). Her experience spans new product development, risk management (ISO 14971), clini...

Experience: 30+ years

Expertise & Specializations

Regulatory Pathways

510(k)De NovoPMAIDEQ-Sub

Device Specialties

CardiovascularRadiologyGeneral SurgeryDentalAnesthesiology

Regions Served

Tammy Lavery provides regulatory consulting services to clients in:

United States (FDA)European Union (MDR/IVDR)Canada (Health Canada)

Credentials & Recognition

Education & Credentials

This professional holds a Bachelor of Science from the University of Utah's College of Health, where they were recognized with the Dean's Outstanding Achievement Award. This strong academic foundation in a health-related field, combined with early recognition for excellence, provides a solid basis for their deep understanding of the scientific and clinical principles essential for navigating complex medical device regulations. Their education is a valuable asset for medtech companies seeking a consultant with both regulatory acumen and a fundamental grasp of health sciences.

This individual's record of high performance was evident early in their career, having been honored with the Dean's Outstanding Achievement Award upon graduating from the University of Utah. This academic distinction underscores a long-standing commitment to excellence and a rigorous, detail-oriented approach. Such recognition highlights a foundation of success that has continued throughout their professional career in the medtech industry.

As a holder of the prestigious Regulatory Affairs Certification (RAC) from RAPS, this professional demonstrates a certified, high-level of expertise and commitment to the regulatory field. Their background also includes experience with ASQ CQA audit principles, signifying a strong foundation in quality systems. These credentials reflect active engagement with leading industry bodies, ensuring their knowledge remains current and aligned with best practices in the global regulatory landscape.

Certifications

Regulatory Affairs Certification
RAPS
Preparing the CMC Section for NDAs/INDs/CTDs
CfPIE
2020
Clinical Research Assistant 10 Week On-Boarding
Barnett International
Collaborative Institutional Training Initiative (Citi Program)
Citi Program

Professional Experience

With over two decades of experience, this executive has a distinguished career in global quality and regulatory affairs within the medical device industry. They have held progressively senior leadership roles, including VP and Senior Director, at notable companies such as Xcision Medical Systems, Owlet Baby Care, and Bard Access Systems. Their experience demonstrates a proven ability to lead global regulatory strategy, manage complex quality management systems (QMS), and guide new product development from concept to market launch. This extensive track record in both established medtech firms and innovative startups makes them a versatile and highly valuable strategic partner for companies at any stage of growth.

Former Big MedTech RA Leader
Enterprise experience

Executive Summary

Professional Overview

A seasoned Global Quality and Regulatory Compliance Executive with over two decades of leadership in the medical device industry. Tammy Lavery possesses deep expertise in securing FDA approvals, developing and implementing global regulatory strategies, and managing robust Quality Management Systems ...

Core Specializations

Regulatory Pathways

510(k)De NovoPMAIDEQ-Sub

Device Specialties

CardiovascularRadiologyGeneral SurgeryDentalAnesthesiology

Services Offered

ISO 13485 Consulting
Quality management system development, gap analysis, and ISO 13485 certification support for medical device manufacturers.
FDA Mock Audit
Pre-inspection preparation, mock FDA audits, and readiness assessments to ensure compliance before official FDA inspections.
ISO 14971 Consulting
Risk management system development, risk analysis, and ISO 14971 compliance support for medical device risk management.
Regulatory Pathway Assessment
Strategic assessment to determine the appropriate FDA regulatory pathway (510(k), De Novo, PMA) for your medical device.
510(k) Authoring & Submission
Complete 510(k) submission preparation, documentation authoring, and FDA submission management.
De Novo & PMA Strategy
Strategic planning and support for De Novo and PMA pathways, including clinical trial design and FDA meeting preparation.
QMS Setup & Implementation
Quality management system design, implementation, and validation to meet FDA and ISO requirements.
Post-Market Support
Post-market surveillance, adverse event reporting, and ongoing regulatory compliance support.

Cruxi Independent Snapshot

Best suited for

  • • MedTech companies seeking expert regulatory guidance

Experience signals

  • Regions: US, EU, CA
  • Background: 30+ years of regulatory experience.

Cruxi view

Tammy Lavery offers medtech companies a powerful combination of executive-level strategic vision and hands-on regulatory execution, backed by 30 years of industry leadership. Her deep expertise spans the most challenging regulatory pathways, including 510(k), De Novo, and PMA submissions, for a wide range of complex devices such as cardiovascular, SaMD, and implantables (Class I-III). What truly distinguishes Tammy is her versatile experience, having served as a VP of RA/QA and a direct consultant, enabling her to effectively guide both startups and large corporations through the entire product lifecycle. She is a proven leader in developing global regulatory strategies for US, EU, and Canadian markets, managing robust ISO 13485/MDSAP compliant QMS, and securing critical market approvals, making her an invaluable asset for achieving commercial success.

This analysis is generated by Cruxi AI using public information and may not capture the full scope of the consultant's experience.

Contact Tammy Lavery

Share a brief overview of your device and timeline. Cruxi will forward your request to Tammy Lavery and help structure next steps.

Contact Now